I-Mab Signs Agreement to Divest its Assets and Business Operations in China
Agreement marks an important milestone to advance the Company’s intent to become a U.S.-based biotech
Agreement provides for a strategic focus in advancing I-Mab’s potential of differentiated oncology clinical asset… อ่านเพิ่ม